
Business & Economy
India drafts tighter rules on drug patent claims
India has proposed revised guidelines for examining pharmaceutical patents, aiming to prevent companies from extending monopolies through minor tweaks to existing medicines. According to the draft, small modifications would need rigorous scientific evidence of enhanced therapeutic efficacy to qualify for protection, a move intended to clear the way for faster entry of affordable generic drugs.
Sources: Mint












































Today's Varta